Browsing: Parkinson’s disease

University of Florida researchers have developed new software that could significantly improve the accuracy and speed of Parkinson’s disease diagnosis.

The Center for Health + Technology (CHeT) at the Del Monte Institute for Neuroscience is pioneering new approaches to clinical research, particularly in the field of neurological disorders.

Koneksa Health is leveraging the popularity of GLP-1 drugs to study their potential in treating Parkinson’s disease, following promising preliminary research.

The Center for Health + Technology (CHeT) at the Del Monte Institute for Neuroscience is at the forefront of transforming clinical research and improving health outcomes for individuals with neurological conditions.